Corvex, Inc. (MOVE) Q4 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Corvex, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.089 -- 00:00:05.890 including a $3 million strategic seed investment from a tier one multi-billion 00:00:05.890 -- 00:00:11.591 dollar global medical device company. This is a pivotal moment in our company's journey. 00:00:11.591 -- 00:00:15.832 We're thrilled to partner with this leader in healthcare and look forward to potential 00:00:15.832 -- 00:00:18.033 future collaborations. 00:00:18.033 -- 00:00:23.214 As we highlighted in our press release earlier this week, this strategic investor is 00:00:23.214 -- 00:00:28.315 keenly interested in the EV ring and our proprietary millimeter wave radio frequency 00:00:28.315 -- 00:00:33.506 technology And this event underscores the vast potential of our innovative 00:00:33.506 -- 00:00:39.728 approach to delivering medical grade data to both consumers and enterprises. 00:00:39.728 -- 00:00:44.809 We're also fortunate to have had the broad participation in the private placement 00:00:44.809 -- 00:00:50.210 from Havana Health's management team and board of directors, totaling more than $3.6 00:00:50.210 -- 00:00:52.091 million. 00:00:52.091 -- 00:00:57.318 Now, with the new financing, we are set up to scale commercial production 00:00:57.318 -- 00:01:02.921 proceed further along the regulatory pathway and pursue multiple market opportunities 00:01:02.921 -- 00:01:06.003 that should deliver shareholder value. 00:01:06.003 -- 00:01:11.026 Our goal is to deliver both the consumer and FDA cleared wearable 00:01:11.026 -- 00:01:14.829 that combines accessibility, personalization, 00:01:14.829 -- 00:01:19.752 and style with the recognized capabilities of a medical device. 00:01:19.752 -- 00:01:24.976 Our highest priorities are as follows. One, to achieve our first 00:01:24.976 -- 00:01:30.080 FDA clearance for pulse...